Xeris Biopharma Holdings, Inc. (XERS)

NASDAQ: XERS · IEX Real-Time Price · USD

2.365

-0.015 (-0.63%)

At close: Jul 19, 2024, 4:00 PM

2.350

-0.015 (-0.63%)

Pre-market: Jul 20, 2024, 9:28 AM EDT

Xeris Biopharma Holdings Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year Ending	TTM	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	2018 - 2016
Revenue	171.36	163.91	110.25	49.59	20.44	2.72	Upgrade
Revenue Growth (YoY)	41.18%	48.68%	122.32%	142.67%	650.73%	12.34%	Upgrade
Cost of Revenue	29.3	28.65	22.63	13.32	9.33	1.6	Upgrade
Gross Profit	142.06	135.27	87.61	36.27	11.11	1.12	Upgrade
Selling, General & Admin	150.87	146.1	137.75	125.72	73.73	63.06	Upgrade
Research & Development	25.32	22.34	20.97	25.16	20.92	60.44	Upgrade
Other Operating Expenses	10.84	10.84	10.84	0.55	0	0	Upgrade
Operating Expenses	187.04	179.28	169.55	151.43	94.65	123.5	Upgrade
Operating Income	-44.98	-44.01	-81.94	-115.16	-83.55	-122.38	Upgrade
Interest Expense / Income	27.43	26.61	14.1	7.18	10.66	7.16	Upgrade
Other Expense / Income	-7.06	-7.12	0.04	0.39	-2.96	-3.51	Upgrade
Pretax Income	-65.34	-63.5	-96.08	-122.73	-91.25	-126.04	Upgrade
Income Tax	-0.94	-1.25	-1.42	0	-0.11	-0.46	Upgrade
Net Income	-64.4	-62.26	-94.66	-122.73	-91.14	-125.58	Upgrade
Shares Outstanding (Basic)	141	138	136	79	43	26	Upgrade
Shares Outstanding (Diluted)	141	138	136	79	43	26	Upgrade
Shares Change	2.46%	1.51%	71.62%	85.32%	63.32%	116.75%	Upgrade
EPS (Basic)	-0.46	-0.45	-0.70	-1.55	-2.14	-4.81	Upgrade
EPS (Diluted)	-0.46	-0.45	-0.70	-1.55	-2.14	-4.81	Upgrade
Free Cash Flow	-43.38	-49.29	-103.42	-96.62	-80.94	-105.45	Upgrade
Free Cash Flow Per Share	-0.31	-0.36	-0.76	-1.22	-1.90	-4.04	Upgrade
Gross Margin	82.90%	82.52%	79.47%	73.14%	54.35%	41.11%	Upgrade
Operating Margin	-26.25%	-26.85%	-74.32%	-232.22%	-408.84%	-4495.96%	Upgrade
Profit Margin	-37.58%	-37.98%	-85.86%	-247.48%	-446.00%	-4613.52%	Upgrade
Free Cash Flow Margin	-25.31%	-30.07%	-93.80%	-194.84%	-396.06%	-3874.10%	Upgrade
EBITDA	-24.73	-23.74	-69.31	-113.67	-79.12	-117.8	Upgrade
EBITDA Margin	-14.43%	-14.48%	-62.87%	-229.21%	-387.19%	-4327.59%	Upgrade
Depreciation & Amortization	13.19	13.16	12.67	1.88	1.47	1.08	Upgrade
EBIT	-37.92	-36.9	-81.98	-115.55	-80.59	-118.88	Upgrade
EBIT Margin	-22.13%	-22.51%	-74.36%	-233.00%	-394.37%	-4367.19%	Upgrade

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).